Corporate Directory

Directors

Geoff Starr – Non-Executive Chairman
Layton Mills – Managing Director
Max Johnston – Non-Executive Director
Robert Clifford – Non-Executive Director
Dr Kate Adams – Non-Executive Director

Company Secretary

Baden Bowen

Corporate Inquiries

Justin Klintberg
Merchant Corporate Advisory
E: Info@merchantgroup.com.au

Share Registry

Computershare Investor Services Pty Limited
Level 11
172 St Georges Terrace
Perth WA 6000

Solicitors

Steinepreis Paganin
Level 4, The Read Buildings
16 Milligan Street
Perth WA 6000

Registered Office

Level 3
45A Bay Street
Double Bay NSW 2028

Telephone: +61 (02) 6108 3622
Email: info@cannpal.com
Website: www.cannpal.com

ASX Code

CP1

Media enquiries

Julia Maguire
The Capital Network
M: +61 (0)419 815 386
E: julia@thecapitalnetwork.com.au

Auditor

BDO Audit (WA) Pty Ltd
38 Station Street
Subiaco WA 6008

Invest in CannPal

CannPal Animal Therapeutics Limited (“CannPal”) is a pharmaceutical-focused animal health company researching the benefits of medical cannabis for companion animals. The company is listed on the Australian Stock Exchange (ASX) in 2017, trading under the ASX ticker “CP1”. CannPal was founded to research, develop and commercialise, regulatory approved medicines derived from the medical cannabis plant to provide veterinarians with clinically validated and standardised therapeutics to treat animals in a safe and ethical way.

Learn More